Your Sculptra treatment

Sculptra renews the skin by improving the appearance of wrinkles up to 25 months after last treatment1.  Before you have your first treatment with Sculptra, you will always have a consultation. Think through what you want to achieve and what questions you may want to ask your healthcare practitioner. We warmly recommend you to read through our Q&A section below to find out more about treatments with Sculptra. 

The first step: Find your clinic

Christoph Martschin, dermatologist, Sweden, gives his best advice on how to find a clinic and a healthcare practitioner that you can trust and be comfortable with. 

Treatment areas

Sculptra increases skin volume and firmness and reduces the appearance of wrinkles.2 

Treatment Areas Sculptro:Cheeks, mid face, lower face
Cheeks, mid face, lower face
Treatment Areas Sculptro:Cheeks, mid face, lower face
Cheeks, mid face, lower face

What to ask your practitioner

Here are a few questions that we recommend you ask your healthcare practitioner: 

•    Is  Sculptra the right product for me?
•    How does Sculptra work?
•    What happens during the treatment?
•    How many treatments do you think I would need?
•    When can I expect to see results?
•    How long will the results last?
•    What are the possible side effects with Sculptra?
•    Are there any ingredients in Sculptra that I may be allergic to?
•    Could my medical history or previous treatments affect or prevent treatment?
•    Is there anything I should do before and after treatment?

Any other question you may have.

You will also find detailed information about treatment with Sculptra in our FAQ section below. 

FREQUENTLY ASKED QUESTIONS

Sculptra is distributed by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries. To read more about Galderma visit About Galderma

Skin insights

REFERENCES

1 Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
2 Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.